Neurodegeneration, or the gradual loss of neuron function, is one of the key features of Alzheimer's disease. However, it doesn't affect all parts of the brain equally.
Johns Hopkins researchers, along with colleagues in Italy, have published a study that looks into the genetic mechanisms behind the development of schizophrenia.
People living with long COVID who suffer from loss of smell show different patterns of activity in certain regions of the brain, a new study led by UCL researchers has found.
Researchers at the University of Campinas and the Federal University of São Carlos in Brazil have developed an electrochemical sensor that detects Parkinson's disease at different stages.
A study led by Dr. Ryosuke Tsuchimochi and Professor Jun Takahashi examined the effects of combining cell transplantation and gene therapy for axonal outgrowth in the central nervous system.
Multiple sclerosis affects three women for every one man. French scientists are studying the role of the sex hormones in order to better understand this discrepancy.
A research team from DGIST develops an electronic medicine technology that restores abnormal protein behavior, the cause of Charcot-Marie-Tooth Disease (CMT).
Cambridge researchers have developed a new type of neural implant that could restore limb function to amputees and others who have lost the use of their arms or legs.
UK researchers have shown that misophonia, a condition where those affected show a strong negative reaction to everyday sounds, may affect almost one fifth of the general population.
A new study by psychologists at the University of Vienna shows that there is no scientific evidence supporting the alleged positive effect of Mozart's Sonata KV448 on epilepsy.
Scientists from Japan demonstrated, for the first time, a successful chemogenetic suppression of widespread epileptic seizures in macaque monkeys. Their findings represent an essential step towards clinical trials, and effective treatment for patients with severe epilepsy.
Experiencing three or more concussions is linked with worsened brain function in later life, according to new research. However, negative effects may already appear after the first injury.
Researchers from Queensland have developed a new fMRI technique with vastly increased temporal resolutions, enabling them to capture the dynamics of brain activity at a sub-second level.
Monitoring the proper blood supply to the brain could be used to prevent or even treat neurological diseases. A new technique called πNIRS aims to do just that.
For almost four decades, stroke cases and fatalities have been on the decline. In recent years, however, signs point to a resurgence, according to an analysis of US stroke deaths from 1975 to 2019.
Findings of bacteria with anti-inflammatory effects in the intestines of MS patients with no evidence of active disease indicate that diet, bacteria and disease progression are linked.
A team of researchers from Portugal and Germany tested an innovative solution to classify seizures, the main symptom of epilepsy, using infrared radar and 3D videos.
After an infection with SARS-CoV-2, some people fail to recover their sense of smell. US researchers took a closer look at the olfactory nerve cells to find the reason for Covid-19-induced anosmia.
Are climate change and air pollution making neurologic diseases like headaches, dementia and multiple sclerosis (MS) worse? A scoping review of research explores the connection.
White matter hyperintensities (WMH) on the brain seen on MRI represent a biomarker associated with a 50/50 risk of death within five years after a first incident acute ischemic stroke (AIS) or transient ischemic attack (TIA).
Researchers mapped in detail how the immune system acts against pathogens invading the brain. This sheds new light on host-pathogen interactions and the long-term consequences of brain infections.
Researchers have shown that when brain cells are directly exposed to blood taken from Covid-19 patients with delirium, there is an increase in cell death and a decrease in the generation of new brain cells.
US researchers have developed a test to detect loss of myelin - a key contributor to many neurological diseases including multiple sclerosis, traumatic brain and spinal cord injuries, stroke, and dementia.
As the monkeypox outbreak continues to spread around the globe, a rare but potentially serious complication of the virus has been discovered.
German researchers present a novel method for testing chemical agents that could help in the development of drugs against neurodegenerative diseases such as Alzheimer's.